Partners4Access

P4A will present three thought provoking posters at ISPOR Europe 2024 in Barcelona. With these posters, P4A showcases its commitment to advancing health economics and outcomes research (HEOR) in orphan drugs and ATMPs.

RarePULSE® Achieves Registered Trademark for Omnichannel Service We are thrilled to announce that RarePULSE® our innovative omnichannel service has officially received registered trademark status from the Intellectual Property Office (IPO).

Partners4Access (P4A), a leading global consultancy specializing in market access for orphan drugs, gene therapies, and rare disease treatments, is excited to announce that three of its poster abstracts have been accepted for presentation

Partners4Access (P4A), a leading global consultancy specializing in orphan drugs, cell and gene therapies, market access, is proud to announce its membership with Health Technology Assessment international (HTAi).

London, United Kingdom, April 29, 2022- Leading specialist market access consultancy Partners4Access analyst's have been awarded 'Highly Commended'' Analyst Team of the Year 2022 by BHBIA BOBI Awards and have been shortlisted to the last four teams as...

Leading specialist market access consultancy Partners4Access (P4A) is to host a free webinar to share insights on key emerging trend in launch strategy for new drugs within EU-5 for pharma/biotech manufacturers.

Leading specialist market access consultancy Partners4Access (P4A) is to host a free webinar to share insights on key 2021 trends in market access for pharma/biotech manufacturers.

Leading specialist market access consultancy Partners4Access (P4A) is to host a free webinar that will share insights on key considerations for pharma/biotech manufacturers on early access program strategy and implementation.

Leading specialist market access consultancy Partners4Access (P4A) has announced it will share insights on gene therapy access for rare diseases at the biotech industry conference World Orphan Drug Congress (WODC) US.

Leading specialist market access consultancy Partners4Access has announced their gold sponsorship of the biotech industry conference World Orphan Drug Congress (WODC) Europe.